![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 32, 24630-24638, August 11, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
,
,
From the An expression library for active site mutants of
human topoisomerase II
First Department of Surgery and the
Laboratories of § Cancer Cell Biology and ¶ Medical
Mycology, Research Institute for Disease Mechanism and Control, Nagoya
University School of Medicine, Nagoya, 466-8550, Japan
(TOP2
) was constructed by replacing the
sequence encoding residues 793-808 with a randomized oligonucleotide
cassette. This plasmid library was transformed into a
temperature-sensitive yeast strain (top2-1), and viable
transformants were selected at the restrictive temperature. Among the
active TOP2
mutants, no substitution was allowed at
Tyr805, the 5' anchor of the cleaved DNA, and only
conservative substitutions were allowed at Leu794,
Asp797, Ala801, and Arg804. Thus,
these 5 residues are critical for human TOP2
activity, and the
remaining mutagenized residues are less critical for function. Using
the x-ray crystal structure of yeast TOP2 as a structural model, it can
be deduced that these 5 functionally important residues lie in a plane.
One of the possible functions of this plane may be that it interacts
with the DNA substrate upon catalysis. The side chains of
Ser803 and Lys798, which confer drug
resistance, lie adjacent to this plane.
To whom correspondence should be addressed. Tel.:
81-52-744-2456; Fax: 81-52-744-2457; E-mail:
msuzuki@tsuru.med.nagoya-u.ac.jp.
This article has been cited by other articles:
![]() |
M. Duca, D. Guianvarc'h, K. Oussedik, L. Halby, A. Garbesi, D. Dauzonne, C. Monneret, N. Osheroff, C. Giovannangeli, and P. B. Arimondo Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotides. Nucleic Acids Res., January 1, 2006; 34(6): 1900 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Suda, Y. Ito, T. Imai, T. Kikumori, A. Kikuchi, Y. Nishiyama, S. Yoshida, and M. Suzuki The {alpha}4 residues of human DNA topoisomerase II{alpha} function in enzymatic activity and anticancer drug sensitivity Nucleic Acids Res., March 16, 2004; 32(5): 1767 - 1773. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sengupta, M. Mukherjee, C. Mandal, A. Das, and H. K. Majumder Functional dissection of the C-terminal domain of type II DNA topoisomerase from the kinetoplastid hemoflagellate Leishmania donovani Nucleic Acids Res., September 15, 2003; 31(18): 5305 - 5316. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xiao, T.-K. Li, J.-M. Yang, and L. F. Liu Acidic pH induces topoisomerase II-mediated DNA damage PNAS, April 29, 2003; 100(9): 5205 - 5210. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Diaz, A. D. Alcid, J. M. Berger, and S. Keeney Identification of Residues in Yeast Spo11p Critical for Meiotic DNA Double-Strand Break Formation Mol. Cell. Biol., February 15, 2002; 22(4): 1106 - 1115. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |